Epirium Bio
PrivateLast Round
Series B
Jul 25, 2025
Total Funding Raised
$85M
Company Overview
Epirium Bio is a biopharmaceutical company that develops therapeutic drugs aimed at treating diseases associated with mitochondrial depletion and dysfunction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epirium Bio Comparables
Compare Epirium Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NMD Pharma | 76% | |
| Rejuvenate Biomed | 75% | |
| ImmunoForge Co., Ltd. | 75% | |
Epirium Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 25, 2025 | ||||
| Series A | Dec 18, 2019 |
Key People
Founding team and executive leadership
Epirium Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series A |
| Vertex Ventures HC | Series A |
| ARCH Venture Partners | Series A |
| ARCH Venture Partners | Series A |
| Bluebird Ventures | Series A |
| The Longevity Fund | Series A |
| Adams Street Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 30% MoM, reaching 4.6K.
- Mar 13, 2025
Presented preclinical data on drug candidate MF-300 at an international conference.
Epirium Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Epirium Bio's valuation, stock price, and market status.